BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150
14 results:

  • 1. Systemic Cisplatin Does Not Affect the Bone Regeneration Process in a Critical Size Defect Murine Model.
    Brozovich AA; Lenna S; Brenner C; Serpelloni S; Paradiso F; McCulloch P; Yustein JT; Weiner B; Taraballi F
    ACS Biomater Sci Eng; 2024 Mar; 10(3):1646-1660. PubMed ID: 38350651
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Myxofibrosarcoma in adolescents and young adults: a clinicopathologic study of 17 cases.
    Arispe Angulo KR; Logan S; Bahrami A; John I; Billings SD; Agrawal S; Bena J; Mesko N; Folpe AL; Fritchie KJ
    Hum Pathol; 2023 Dec; 142():90-95. PubMed ID: 37742946
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
    Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
    Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta-analysis.
    van Weelden WJ; Birkendahl PB; Lalisang RI; IntHout J; Kruitwagen RFPM; Romano A; Pijnenborg JMA
    BJOG; 2023 Jan; 130(2):143-152. PubMed ID: 36264251
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.
    Hingorani P; Krailo M; Buxton A; Hutson P; Sondel PM; Diccianni M; Yu A; Morris CD; Womer RB; Crompton B; Randall RL; Teot LA; DuBois SG; Janeway KA; Gorlick RG; Isakoff MS
    Eur J Cancer; 2022 Sep; 172():264-275. PubMed ID: 35809374
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Spindle cell/sclerosing rhabdomyosarcoma with dctn1::ALK fusion: broadening the molecular spectrum with potential therapeutic implications.
    Fung CK; Chow C; Chan WK; Choi EWK; To KF; Chan JKC; Cheuk W
    Virchows Arch; 2022 Apr; 480(4):927-932. PubMed ID: 35229187
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
    Gounder M; Schöffski P; Jones RL; Agulnik M; Cote GM; Villalobos VM; Attia S; Chugh R; Chen TW; Jahan T; Loggers ET; Gupta A; Italiano A; Demetri GD; Ratan R; Davis LE; Mir O; Dileo P; Van Tine BA; Pressey JG; Lingaraj T; Rajarethinam A; Sierra L; Agarwal S; Stacchiotti S
    Lancet Oncol; 2020 Nov; 21(11):1423-1432. PubMed ID: 33035459
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Larotrectinib followed by selitrectinib in a novel
    Goh XN; Seng MS; Loh AHP; Gupta A; Chang KTE; Iyer P
    J Oncol Pharm Pract; 2021 Mar; 27(2):485-489. PubMed ID: 32693686
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
    Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
    J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring dctn1-ALK fusion.
    Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM
    J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnosis and grading of chondrosarcomas on FNA biopsy material.
    Lerma E; Tani E; Brosjö O; Bauer H; Söderlund V; Skoog L
    Diagn Cytopathol; 2003 Jan; 28(1):13-7. PubMed ID: 12508176
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Extrauterine low-grade endometrial stromal sarcoma: report of three cases.
    Fukunaga M; Ishihara A; Ushigome S
    Pathol Int; 1998 Apr; 48(4):297-302. PubMed ID: 9648159
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spinal cord tumors in the People's Republic of China: a statistical review.
    Cheng MK
    Neurosurgery; 1982 Jan; 10(1):22-4. PubMed ID: 7057974
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.